Global Lateral Flow Assay Market

1 INTRODUCTION OF GLOBAL LATERAL FLOW ASSAY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL LATERAL FLOW ASSAY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 Global Lateral Flow Assay Market, by Application:
5.1 Clinical/Point-of-Care Testing
5.1.1 Infectious Disease Testing
5.1.1.1 Mosquito-Borne Disease Testing
5.1.1.2 Influenza Testing
5.1.1.3 Sexually Transmitted Infections
5.1.1.4 Hepatitis
5.1.1.5 Tuberculosis
5.1.1.6 Other Infectious Diseases

5.1.2 Cardiac Marker Testing

5.1.3 Pregnancy & Fertility Testing
5.1.3.1 Pregnancy Testing
5.1.3.2 Fertility Testing

5.1.4 Cholesterol/Lipid Testing
5.1.5 Drugs-of-Abuse Testing

5.2 Veterinary Diagnostics
5.3 Food Safety & Environment Testing
5.4 Drug Development & Quality Testing

6 Global Lateral Flow Assay Market, by End User:
6.1 Hospitals and Clinics
6.2 Home Care
6.3 Diagnostic Laboratories
6.4 Other End Users

7 Global Lateral Flow Assay Market, by Technique:
7.1 Sandwich Assays
7.2 Competitive Assays
7.3 Multiplex Detection Assays

8 GLOBAL LATERAL FLOW ASSAY MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL LATERAL FLOW ASSAY MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Alere Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 F. Hoffmann-La Roche AG
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Danaher Corporation
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Siemens AG
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Johnson & Johnson
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Becton, Dickinson and Company
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Biomérieux SA
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Bio-Rad Laboratories, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Thermo Fisher Scientific Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Qiagen N.V.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Perkinelmer Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Abbott Laboratories
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Hologic, Inc.
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Quidel Corporation
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

11 Appendix
11.1 Related Reports